← Browse by Condition
Medical Condition
membranous nephropathy
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2
ClinicalMetric tracks all active clinical trials for membranous nephropathy sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — membranous nephropathy Clinical Trials
How many clinical trials are currently recruiting for membranous nephropathy?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for membranous nephropathy, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for membranous nephropathy?
membranous nephropathy research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a membranous nephropathy clinical trial?
Eligibility criteria for membranous nephropathy trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06065852
Recruiting
National Registry of Rare Kidney Diseases
Enrollment
35,000 pts
Location
United Kingdom
Sponsor
UK Kidney Association
NCT03949855 Phase 2
Recruiting
Belimumab With Rituximab for Primary Membranous Nephropathy
Enrollment
58 pts
Location
United States
Sponsor
National Institute of Allergy ...
NCT06760845
Recruiting
Raman Spectroscopy Diagnosis of Kidney Diseases
Enrollment
200 pts
Location
China
Sponsor
Zunsong Wang
NCT05688865
Recruiting
Correlation and Clinical Utility of Urinary Biomarker in Membranous Glomerulonephritis
Enrollment
50 pts
Location
Hong Kong
Sponsor
Chinese University of Hong Kon...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology